Healthcare professionals have been notified by the manufacturers of CellCept (mycophenolate mofetil) and Myfortic (mycophenolic acid) that these drugs, in combination with other immunosuppressive agents, have been associated with cases of pure red cell aplasia. Both drugs are used to prevent organ rejection in transplant patients.
Link to this comment:
All Comments (0)